FDA does U-turn, will review Moderna's mRNA flu shot after shocking rejection
FDA does U-turn, will review Moderna's mRNA flu shot after shocking rejection is drawing significant interest across the industry.
Trump admin's vaccine chief overruled FDA scientists to initially reject the shot.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Five Trends That Will Define Shopify Development in 2026 and Beyond
- What are today's mortgage interest rates: March 6, 2026?
- Marquis sues firewall provider SonicWall, alleges security failings with its firewall backup led to ransomware attack
- South Korea's Special Trade Bill: A Move to Meet US Expectations
Source: Original →